C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer

Immune molecules, which have been found to be important in tumor microenvironment, seem prospective in tumor therapy, but they are still not effective enough to use in clinical practice. C-C motif chemokine 22 (CCL22) exists in various malignancies and correlates with migration of regulatory T cells...

Full description

Bibliographic Details
Main Authors: Songyang Wu, Hongyong He, Hao Liu, Yifan Cao, Rochen Li, Heng Zhang, He Li, Zhenbin Shen, Jing Qin, Jiejie Xu
Format: Article
Language:English
Published: Taylor & Francis Group 2018-06-01
Series:OncoImmunology
Subjects:
adjuvant chemotherapy
c-c motif chemokine 22
gastric cancer
prognosis
tumor microenvironment
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1433517

Internet

http://dx.doi.org/10.1080/2162402X.2018.1433517

Similar Items